RENEW OR SUBSCRIBE TO PPM
Subscription is FREE for qualified healthcare professionals in the US.
Subscribe or renew to PPM

All News and Research Articles

The Food and Drug Administration has expanded the indication for methylnaltrexone bromide (Relistor) to include OIC in patients with noncancer pain
Trigeminal neuralgia (TN) is a debilitating chronic pain condition affecting the trigeminal nerve, where patients experience intense facial pain, which can become intractable.
A new study has found that lower opioid overdose death rates were associated with implementation of state medical marijuana laws, although the reason why remains unclear.
The US Food and Drug Administration has approved Movantik (naloxegel) as an oral treatment of opioid-induced constipation in adults with chronic non-cancer pain.
Starting October 9, 2014, the Drug Enforcement Agency (DEA) has announced that they will allow consumers to drop-off unused prescription medications like controlled substances, including opioid, to their local pharmacies.
Adding corticosteroids to epidural lidocaine injections in patients with central canal lumbar spinal stenosis did not increase efficacy, raising the question of whether steroids should be used in this setting, researchers reported in the New England Journal of Medicine.1
The the epidemic of prescription drug misuse and abuse has raised awareness among primary care physicians and pain specialists about the need to screen patients before prescribing addictive medications.  This is especially important when dealing with patients in chronic pain. It is estimated that between 1.9 million people in the U.S.
Doctors commonly recommend acetaminophen as a first-line treatment for many types of aches and pain, but a new study finds the drug may be wholly ineffective in aiding patients with acute low back pain.
Two arthritis medications have shown efficacy in clinical trials—a phase II trial of brodalumab in the treatment of psoriatic arthritis and a phase III trial of tofacitinib in the treatment of
The US Food and Drug Administration (FDA) has approved Targiniq ER (oxycodone and naloxone, Purdue Pharma), as a treatment for severe pain. This is the second approval of a long-acting, extended-release opioid with “abuse deterrent” properties since the FDA issued industry guidelines in 2013.
The Drug Enforcement Administration (DEA) has officially changed tramadol from a non-classified drug to a schedule IV drug, effective August 18, 2014.1 First approved by the US Food and Drug Administration (FDA)  in 1995, tramadol (Ultram) is a centrally acting opioid analgesic.
Tau protein levels and other types of biomarkers may help doctors better diagnose concussions and even monitor symptoms, according to new research. A recent study looked at professional hockey players in Sweden, monitoring their tau protein levels after physical exertion and concussion injuries.
It has long been known that music can be used to calm and relax people. A new study also shows that music therapy can be used to reduce postoperative pain.
People with chronic low back pain appear to lose their enjoyment of eating, resulting in a blunting of feelings of satisfaction, satiety, and pleasure. This can lead to a cycle of over-eating and weight gain, which than contribute to continued low back pain. Innovative new research is now examining how pain influences eating behaviors that led to obesity.
Do unconscious patients experience pain? And if so, how does one measure pain in a non-responsive patient? According to Canadian researchers, respiratory rates (RR) of traumatic brain injury (TBI) patients may be one vital sign used to monitor pain levels in conscious and unconscious patients in the intensive care unit.
close X
SHOW MAIN MENU
SHOW SUB MENU